← FDA DRUG APPROVALS

FDA ANDA · ANDA087550

BUTALBITAL AND ACETAMINOPHEN

Sponsor: WATSON LABS

APPLICATION
ANDA087550
TYPE
ANDA
ORIGINAL APPROVAL
1984-10-19
LATEST ACTION
1993-11-12
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

BUTALBITAL AND ACETAMINOPHEN · ReferenceDiscontinued
ACETAMINOPHEN 325MG, BUTALBITAL 50MG · TABLET · ORAL

Approval history

1993-11-12Labeling · Supplement 3AP
1992-02-26Labeling · Supplement 2AP
1992-01-08Labeling · Supplement 1AP
1984-10-19OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →